RT Journal
A1 Chodick G, Shalev V
T1 Statins and all-cause mortality in high-risk primary prevention: A second look at the results
JF Archives of Internal Medicine
JO Archives of Internal Medicine
YR 2010
FD December 13
VO 170
IS 22
SP 2041
OP 2042
DO 10.1001/archinternmed.2010.456
UL http://dx.doi.org/10.1001/archinternmed.2010.456
AB 
In summarizing the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) study,2 the authors calculated a risk ratio of 0.98, while the original publication reported a risk ratio of 0.87. This change alone may have biased against finding a statistically significant benefit for statin use.